- Home
- KURA vs MCBS Comparison
KURA vs MCBS Comparison
Compare KURA & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | MCBS |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | 260 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.6M | 816.1M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KURA | MCBS |
|---|---|---|
| Price | $9.23 | $31.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $25.56 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 1.2M | 54.9K |
| Earning Date | 05-12-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | N/A | ★ 4.76 |
| EPS | N/A | ★ 0.77 |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $36.78 |
| Revenue Next Year | $106.37 | $2.44 |
| P/E Ratio | ★ N/A | $41.01 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $24.53 |
| 52 Week High | $12.49 | $33.67 |
Technical Indicators
Market Signals| Indicator | KURA | MCBS |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 47.66 |
| Support Level | $8.95 | $30.72 |
| Resistance Level | $9.82 | $33.38 |
| Average True Range (ATR) | 0.43 | 0.79 |
| MACD | 0.01 | -0.22 |
| Stochastic Oscillator | 50.34 | 9.69 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.